ArticleOrthopaedic journal of sports medicine2025
Complications and Outcomes of Chemically Treated Allograft in Preadolescent and Adolescent Patients Undergoing Medial Patellofemoral Ligament Reconstruction.
Article in Orthopaedic journal of sports medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A Comprehensive Guide to Revision Medial Patellofemoral Ligament Reconstruction in Adolescents.Journal of the Pediatric Orthopaedic Society of North America · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Chemically treated allografts (CTAs) have been developed with the goal of providing a graft that is fully sterilized while maintaining the structural integrity and biochemical properties of the graft without irradiation. Few studies have analyzed the complications and postoperative outcomes of CTA in medial patellofemoral ligament (MPFL) reconstruction. Hypothesis: The rate of complications and the outcomes of pediatric patients undergoing MPFL reconstruction would be similar between CTAs and low-dose irradiated allografts (IAs). Study Design: Cohort study; Level of evidence, 3. Methods: The medical charts of a consecutive cohort of pediatric patients (aged 12-18 years) who underwent MPFL reconstruction at a single center from June 2011 to September 2022 with either 1- or 2-year follow-up were retrospectively reviewed. Patient characteristics, operative data, and postoperative data were collected in those without diagnosed collagen disorder or multiligament reconstruction. Without deliberate allocation, CTAs were overwhelmingly gracilis tendon allografts, whereas the majority of IAs were semitendinosus. Complications were recorded and included infection, redislocation, and reoperation. Patient-reported outcomes were collected including the Single Assessment Numeric Evaluation score, Kujala score, overall rating of treatment satisfaction, and pain score. Results: A total of 235 (114 CTA, 121 IA) patients had 1-year follow-up with no significant differences in complication rate noted between the cohorts (CTA: 6/114 [5.3%]; IA: 5/121 [4.1%]; Conclusion: CTA and IA for reconstruction of the MPFL in the pediatric patient demonstrate similarly low rates of complication, patellar redislocation, and need for revision surgery. Moreover, the outcomes appear to indicate that utilization of gracilis tendon CTA carries the same risk as low-dose semitendinosus IAs when managing children with MPFL reconstruction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.